Joel Isaacson & Co. LLC Invests $228,000 in Corteva, Inc. $CTVA

Joel Isaacson & Co. LLC bought a new position in Corteva, Inc. (NYSE:CTVA) during the 2nd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm bought 3,059 shares of the company’s stock, valued at approximately $228,000.

Several other institutional investors have also made changes to their positions in CTVA. Moody National Bank Trust Division boosted its stake in shares of Corteva by 0.7% in the 2nd quarter. Moody National Bank Trust Division now owns 22,139 shares of the company’s stock valued at $1,650,000 after purchasing an additional 143 shares in the last quarter. Ancora Advisors LLC boosted its stake in shares of Corteva by 0.8% in the 1st quarter. Ancora Advisors LLC now owns 18,567 shares of the company’s stock valued at $1,168,000 after purchasing an additional 150 shares in the last quarter. NewEdge Advisors LLC boosted its stake in shares of Corteva by 0.5% in the 1st quarter. NewEdge Advisors LLC now owns 31,455 shares of the company’s stock valued at $1,979,000 after purchasing an additional 152 shares in the last quarter. Plancorp LLC boosted its stake in shares of Corteva by 2.3% in the 1st quarter. Plancorp LLC now owns 7,156 shares of the company’s stock valued at $450,000 after purchasing an additional 158 shares in the last quarter. Finally, Legacy Financial Advisors Inc. boosted its stake in shares of Corteva by 4.4% in the 1st quarter. Legacy Financial Advisors Inc. now owns 3,761 shares of the company’s stock valued at $237,000 after purchasing an additional 160 shares in the last quarter. 81.54% of the stock is currently owned by institutional investors and hedge funds.

Insider Transactions at Corteva

In other Corteva news, EVP Robert D. King sold 37,280 shares of the company’s stock in a transaction that occurred on Friday, August 29th. The stock was sold at an average price of $74.20, for a total transaction of $2,766,176.00. Following the completion of the transaction, the executive vice president owned 49,262 shares of the company’s stock, valued at $3,655,240.40. This represents a 43.08% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available through this link. Insiders own 0.14% of the company’s stock.

Corteva Price Performance

NYSE CTVA opened at $63.10 on Thursday. The business has a 50 day simple moving average of $70.75 and a 200 day simple moving average of $68.90. Corteva, Inc. has a 52-week low of $53.40 and a 52-week high of $77.41. The company has a debt-to-equity ratio of 0.06, a quick ratio of 1.23 and a current ratio of 1.68. The stock has a market cap of $42.85 billion, a price-to-earnings ratio of 30.78, a PEG ratio of 1.48 and a beta of 0.76.

Corteva (NYSE:CTVA) last posted its earnings results on Wednesday, August 6th. The company reported $2.20 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.89 by $0.31. Corteva had a return on equity of 8.68% and a net margin of 8.16%.The business had revenue of $6.46 billion during the quarter, compared to analysts’ expectations of $6.26 billion. During the same period in the prior year, the business earned $1.83 EPS. Corteva’s revenue for the quarter was up 5.6% compared to the same quarter last year. Analysts anticipate that Corteva, Inc. will post 2.96 earnings per share for the current fiscal year.

Corteva Increases Dividend

The firm also recently announced a quarterly dividend, which was paid on Monday, September 15th. Investors of record on Tuesday, September 2nd were paid a dividend of $0.18 per share. This represents a $0.72 dividend on an annualized basis and a yield of 1.1%. The ex-dividend date of this dividend was Tuesday, September 2nd. This is a positive change from Corteva’s previous quarterly dividend of $0.17. Corteva’s dividend payout ratio (DPR) is currently 35.12%.

Analyst Upgrades and Downgrades

Several brokerages recently issued reports on CTVA. BMO Capital Markets set a $86.00 price target on shares of Corteva in a research report on Monday, September 15th. Jefferies Financial Group reduced their price target on shares of Corteva from $92.00 to $85.00 in a research report on Thursday, October 2nd. JPMorgan Chase & Co. upgraded shares of Corteva from a “neutral” rating to an “overweight” rating and set a $67.00 price target on the stock in a research report on Thursday, October 2nd. Mizuho reduced their price target on shares of Corteva from $85.00 to $78.00 and set an “outperform” rating on the stock in a research report on Wednesday. Finally, Deutsche Bank Aktiengesellschaft upped their price target on shares of Corteva from $83.00 to $90.00 and gave the stock a “buy” rating in a research report on Monday, September 15th. One investment analyst has rated the stock with a Strong Buy rating, fourteen have given a Buy rating and four have issued a Hold rating to the stock. According to MarketBeat.com, Corteva has a consensus rating of “Moderate Buy” and an average target price of $80.13.

Corteva Company Profile

Corteva, Inc operates in the agriculture business. It operates through two segments, Seed and Crop Protection. The Seed segment develops and supplies advanced germplasm and traits that produce optimum yield for farms. It offers trait technologies that enhance resistance to weather, disease, insects, and herbicides used to control weeds, as well as food and nutritional characteristics.